Market Insights Health Hospitals Inpatient Care

Treatment of Musculoskeletal Diseases - South Korea

South Korea

The Treatment of Musculoskeletal Diseases market in South Korea is forecasted to achieve a revenue of €2.47bn in 2024.
Looking ahead, the market is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 3.76%, leading to a market volume of €2.97bn by 2029.
When compared globally, United States is projected to generate the highest revenue, amounting to €55,790.00m in 2024.
South Korea is emerging as a leader in innovative and advanced treatments for musculoskeletal diseases.

Key regions: Europe, Canada, United States, Germany, India

Mercado

Región

Comparación de regiones

Moneda

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.